Harrow News Today Oct 6, 2025 · Harrow is redefining the st
Harrow News Today Oct 6, 2025 · Harrow is redefining the standard of care in eyecare with a portfolio of trusted, high-value pharmaceutical solutions that deliver proven safety, efficacy, and affordability, Harrow was founded to advance the standard of eye care and deliver safe, effective, accessible, and affordable medications that enhance patient compliance and improve clinical outcomes Oct 27, 2025 · The Company will also post its third quarter Letter to Stockholders to the “Investors” section of its website, harrow, Humility, ownership, preparedness, and entrepreneurship create the foundation for a culture where initiative is celebrated, creativity thrives, and impact is real, Nov 18, 2025 · Integration into Harrow: Melt Pharmaceuticals will be fully integrated into Harrow’s operations to ensure a seamless transition and accelerate progress toward NDA submission, approval, and market launch, Eastern Time on Tuesday, November 11, 2025, to discuss the results and provide a business update, Sep 30, 2025 · In September 2025, Harrow announced the launch of Harrow Access for All (HAFA), expanding Harrow’s commitment to make it easier and more affordable for patients to access Harrow’s full range of branded, generic, and compounded ophthalmic medications, At Harrow, our values aren’t just guiding words—they shape how we grow, innovate, and work together, Harrow will host a conference call and live webcast at 8:00 a, Sep 8, 2025 · Harrow was founded with a commitment to deliver safe, effective, accessible, and affordable medications that enhance patient compliance and improve clinical outcomes, Harrow has contracted for the U, S, These products will be added to this section once they are launched by Harrow, commercial rights to BYQLOVI™, BYOOVIZ®, and OPUVIZ™, , m, Nov 11, 2025 · Harrow, a leading provider of ophthalmic disease management solutions in North America, was founded with a commitment to deliver safe, effective, accessible, and affordable medications that enhance patient compliance and improve clinical outcomes, Harrow INC SEC filing: Form 8-K iXBRL on 09/09/2025 (0001493152-25-012840), Oct 6, 2025 · Harrow is redefining the standard of care in eyecare with a portfolio of trusted, high-value pharmaceutical solutions that deliver proven safety, efficacy, and affordability, com,